格隆汇3月14日丨兴业控股(00132.HK)公布,于2025年3月14日,买方(公司的全资附属公司)、研究院、周荣、卖方及目标公司呼研所医药科技(广州)有限公司订立股权转让协议,据此,其中包括,买方有条件同意向卖方购买销售股份(占目标公司股权51%),总代价为人民币5443.53万元,可予调整。据悉,目标公司为一间于2009年10月28日在中国成立的有限责任公司,于公布日期,其注册及实缴资本分别...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.